An open-label, multicenter, three-stage, phase II study of S-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer

Alan Sandler, Charles Graham, Maria Baggstrom, Roy Herbst, Christopher Zergebel, Kaku Saito, Dennie Jones

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, multicenter, three-stage, phase II study of S-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences